{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:38:15Z","timestamp":1773859095305,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Changsha Project","award":["kq2202487"],"award-info":[{"award-number":["kq2202487"]}]},{"name":"the Scientific Research Project of Hunan Aerospace Hospital","award":["2022yj19"],"award-info":[{"award-number":["2022yj19"]}]},{"name":"Science Foundation of the AMHT Group","award":["NO.2022YK04"],"award-info":[{"award-number":["NO.2022YK04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87120-6","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T17:27:35Z","timestamp":1739554055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of 25-hydroxyvitamin D with Parkinson\u2019s disease based on the results from the NHANES 2007 to 2018 and Mendelian randomization analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Yan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiguo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanzhen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"6","key":"87120_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and treatment of Parkinson disease: A review. JAMA 323(6), 548\u2013560 (2020).","journal-title":"JAMA"},{"issue":"1","key":"87120_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye, H. et al. Genetics and pathogenesis of Parkinson\u2019s syndrome. Annu. Rev. Pathol. 18(1), 95\u2013121 (2023).","journal-title":"Annu. Rev. Pathol."},{"issue":"11","key":"87120_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R. et al. Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17(11), 939\u2013953 (2018).","journal-title":"Lancet Neurol."},{"issue":"10423","key":"87120_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo, Y. et al. The epidemiology of Parkinson\u2019s disease. Lancet 403(10423), 283\u2013292 (2024).","journal-title":"Lancet"},{"issue":"12","key":"87120_CR5","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: Risk factors and prevention. Lancet Neurol. 15(12), 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"issue":"2","key":"87120_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","volume":"10","author":"AL McCormack","year":"2002","unstructured":"McCormack, A. L. et al. Environmental risk factors and Parkinson\u2019s disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 10(2), 119\u2013127 (2002).","journal-title":"Neurobiol. Dis."},{"key":"87120_CR7","doi-asserted-by":"crossref","unstructured":"Lv, L. et al. The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson\u2019s disease. Transl. Neurodegener. 9(1) (2020).","DOI":"10.1186\/s40035-020-00213-2"},{"key":"87120_CR8","doi-asserted-by":"publisher","first-page":"117606","DOI":"10.1016\/j.jns.2021.117606","volume":"428","author":"C Agliardi","year":"2021","unstructured":"Agliardi, C. et al. The VDR FokI (rs2228570) polymorphism is involved in Parkinson\u2019s disease. J. Neurol. Sci. 428, 117606 (2021).","journal-title":"J. Neurol. Sci."},{"key":"87120_CR9","doi-asserted-by":"crossref","unstructured":"Sandeep et al. Could vitamins have a positive impact on the treatment of Parkinson\u2019s disease?. Brain Sci. 13(2) (2023).","DOI":"10.3390\/brainsci13020272"},{"issue":"7","key":"87120_CR10","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/mds.26639","volume":"31","author":"GW Ross","year":"2016","unstructured":"Ross, G. W., Petrovitch, H. & Abbott, R. D. Serum vitamin D and risk of Parkinson\u2019s disease. Mov. Disord. 31(7), 993\u2013935 (2016).","journal-title":"Mov. Disord."},{"key":"87120_CR11","doi-asserted-by":"crossref","unstructured":"Xu, S. et al. Causal associations of 25-hydroxyvitamin D with functional gastrointestinal disorders: A two-sample Mendelian randomization study. Genes Nutr. 18, 14 (2023).","DOI":"10.1186\/s12263-023-00734-1"},{"issue":"1","key":"87120_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/joim.12279","volume":"277","author":"C Annweiler","year":"2015","unstructured":"Annweiler, C. et al. Vitamin D and cognition in older adults\u2019: Updated international recommendations. J. Intern. Med. 277(1), 45\u201357 (2015).","journal-title":"J. Intern. Med."},{"issue":"1","key":"87120_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/joim.12308","volume":"277","author":"MF Holick","year":"2015","unstructured":"Holick, M. F. Vitamin D and brain health: The need for vitamin D supplementation and sensible sun exposure. J. Intern. Med. 277(1), 90\u201393 (2015).","journal-title":"J. Intern. Med."},{"issue":"4","key":"87120_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11064-006-9048-4","volume":"31","author":"MP Smith","year":"2006","unstructured":"Smith, M. P. et al. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem. Res. 31(4), 533\u2013539 (2006).","journal-title":"Neurochem. Res."},{"issue":"5","key":"87120_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/pmic.200600392","volume":"7","author":"L Almeras","year":"2007","unstructured":"Almeras, L. et al. Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders. Proteomics 7(5), 769\u2013780 (2007).","journal-title":"Proteomics"},{"issue":"4","key":"87120_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tins.2019.01.003","volume":"42","author":"PE Mayne","year":"2019","unstructured":"Mayne, P. E. & Burne, T. H. J. Vitamin D in synaptic plasticity, cognitive function, and neuropsychiatric illness. Trends Neurosci. 42(4), 293\u2013306 (2019).","journal-title":"Trends Neurosci."},{"issue":"4","key":"87120_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/mds.21317","volume":"22","author":"HL Newmark","year":"2007","unstructured":"Newmark, H. L. & Newmark, J. Vitamin D and Parkinson\u2019s disease\u2013a hypothesis. Mov. Disord. 22(4), 461\u2013468 (2007).","journal-title":"Mov. Disord."},{"key":"87120_CR18","first-page":"127","volume":"12","author":"W Kuhn","year":"2022","unstructured":"Kuhn, W., Karp, G. & M\u00fcller, T. No Vitamin D deficiency in patients with Parkinson\u2019s disease. Degener. Neurol. Neuromuscul. Dis. 12, 127\u2013131 (2022).","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"issue":"7","key":"87120_CR19","doi-asserted-by":"publisher","first-page":"e39227","DOI":"10.1371\/journal.pone.0039227","volume":"7","author":"ED Dean","year":"2012","unstructured":"Dean, E. D. et al. 25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in mice. PloS One 7(7), e39227 (2012).","journal-title":"PloS One"},{"issue":"7","key":"87120_CR20","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/mds.26573","volume":"31","author":"S Shrestha","year":"2016","unstructured":"Shrestha, S. et al. Serum 25-hydroxyvitamin D concentrations in Mid-adulthood and Parkinson\u2019s disease risk. Mov. Disord. 31(7), 972\u2013978 (2016).","journal-title":"Mov. Disord."},{"issue":"11","key":"87120_CR21","doi-asserted-by":"publisher","first-page":"e0313631","DOI":"10.1371\/journal.pone.0313631","volume":"19","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. No association between genetically predicted vitamin D levels and Parkinson\u2019s disease. PloS One 19(11), e0313631 (2024).","journal-title":"PloS One"},{"issue":"4","key":"87120_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden, J. & Holmes, M. V. Meta-analysis and Mendelian randomization: A review. Res. Synth. Methods 10(4), 486\u2013496 (2019).","journal-title":"Res. Synth. Methods"},{"key":"87120_CR23","doi-asserted-by":"crossref","unstructured":"Smith, G. D. & Ebrahim, S. \u2018Mendelian randomization\u2019: Can genetic epidemiology contribute to understanding environmental determinants of disease?. Int. J. Epidemiol. 32(1) (2003).","DOI":"10.1093\/ije\/dyg070"},{"issue":"1","key":"87120_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12263-010-0181-y","volume":"6","author":"G Davey Smith","year":"2011","unstructured":"Davey Smith, G. Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health. Genes Nutr. 6(1), 27\u201343 (2011).","journal-title":"Genes Nutr."},{"issue":"1","key":"87120_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41531-023-00591-0","volume":"9","author":"XJ Gu","year":"2023","unstructured":"Gu, X. J. et al. Expanding causal genes for Parkinson\u2019s disease via multi-omics analysis. NPJ Parkinsons Dis. 9(1), 146 (2023).","journal-title":"NPJ Parkinsons Dis."},{"issue":"R1","key":"87120_CR26","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith, G. & Hemani, G. Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23(R1), R89\u2013R98 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"87120_CR27","unstructured":"Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). About the National Health and Nutrition Examination Survey. Available from: https:\/\/www.cdc.gov\/nchs\/nhanes\/about\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/nchs\/nhanes\/about_nhanes.htm (2023)."},{"issue":"13","key":"87120_CR28","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2021.15187","volume":"326","author":"J He","year":"2021","unstructured":"He, J. et al. Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999\u20132018. JAMA 326(13), 1286\u20131298 (2021).","journal-title":"JAMA"},{"issue":"1","key":"87120_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12916-022-02510-1","volume":"20","author":"Q Xiao","year":"2022","unstructured":"Xiao, Q. et al. L-shaped association of serum 25-hydroxyvitamin D concentrations with cardiovascular and all-cause mortality in individuals with osteoarthritis: Results from the NHANES database prospective cohort study. BMC Med. 20(1), 308 (2022).","journal-title":"BMC Med."},{"key":"87120_CR30","doi-asserted-by":"crossref","unstructured":"Tian, X. et al. Physical activity reduces the role of blood cadmium on depression: A cross-sectional analysis with NHANES data. Environ. Pollut. 304, 119211 (1987).","DOI":"10.1016\/j.envpol.2022.119211"},{"issue":"2","key":"87120_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/jcpe.13736","volume":"50","author":"W Li","year":"2023","unstructured":"Li, W. et al. Association between circulating 25-hydroxyvitamin D metabolites and periodontitis: Results from the NHANES 2009\u20132012 and Mendelian randomization study. J. Clin. Periodontol. 50(2), 252\u2013264 (2023).","journal-title":"J. Clin. Periodontol."},{"issue":"7","key":"87120_CR32","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(7), 1911\u20131930 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"87120_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000527537","volume":"86","author":"S Xu","year":"2023","unstructured":"Xu, S., Li, W. & Di, Q. Association of Dietary Patterns with Parkinson\u2019s disease: A cross-sectional study based on the United States National Health and Nutritional examination survey database. Eur. Neurol. 86(1), 63\u201372 (2023).","journal-title":"Eur. Neurol."},{"key":"87120_CR34","doi-asserted-by":"crossref","unstructured":"Zeng, Z., Cen, Y. & Luo, X. Association Between Blood Selenium with Parkinson\u2019s Disease in the US (NHANES 2011\u20132020) (Environmental Science and Pollution Research, 2023).","DOI":"10.21203\/rs.3.rs-2500141\/v1"},{"issue":"3","key":"87120_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ajhg.2020.01.017","volume":"106","author":"D Manousaki","year":"2020","unstructured":"Manousaki, D. et al. Genome-wide association study for Vitamin D levels reveals 69 independent loci. Am. J. Hum. Genet. 106(3), 327\u2013337 (2020).","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"87120_CR36","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12(3), e1001779 (2015).","journal-title":"PLoS Med."},{"issue":"12","key":"87120_CR37","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: A meta-analysis of genome-wide association studies. Lancet Neurol. 18(12), 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"87120_CR38","unstructured":"MA, N. Parkinson\u2019s disease Dataset: ieu-b-7. Available from: https:\/\/gwas.mrcieu.ac.uk\/datasets\/ieu-b-7\/ (2019)."},{"issue":"1","key":"87120_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40035-020-00213-2","volume":"9","author":"L Lv","year":"2020","unstructured":"Lv, L. et al. The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson\u2019s disease. Transl. Neurodegener. 9(1), 34 (2020).","journal-title":"Transl. Neurodegener."},{"issue":"2","key":"87120_CR40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/mds.24016","volume":"27","author":"M Suzuki","year":"2012","unstructured":"Suzuki, M. et al. 25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson\u2019s disease. Mov. Disord. 27 (2), 264\u2013271 (2012).","journal-title":"Mov. Disord."},{"issue":"6","key":"87120_CR41","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1080\/1028415X.2020.1840117","volume":"25","author":"M Barichella","year":"2022","unstructured":"Barichella, M. et al. Clinical correlates of serum 25-hydroxyvitamin D in Parkinson\u2019s disease. Nutr. Neurosci. 25(6), 1128\u20131136 (2022).","journal-title":"Nutr. Neurosci."},{"issue":"1","key":"87120_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10072-013-1539-x","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu, Y. & Zhang, B. S. Serum 25-hydroxyvitamin D predicts severity in Parkinson\u2019s disease patients. Neurol. Sci. 35(1), 67\u201371 (2014).","journal-title":"Neurol. Sci."},{"key":"87120_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neulet.2013.12.053","volume":"561","author":"MS Petersen","year":"2014","unstructured":"Petersen, M. S. et al. The role of vitamin D levels and vitamin D receptor polymorphism on Parkinson\u2019s disease in the Faroe Islands. Neurosci. Lett. 561, 74\u201379 (2014).","journal-title":"Neurosci. Lett."},{"issue":"4","key":"87120_CR44","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/mds.26117","volume":"30","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Vitamin D from different sources is inversely associated with Parkinson disease. Mov. Disord. 30(4), 560\u2013566 (2015).","journal-title":"Mov. Disord."},{"key":"87120_CR45","doi-asserted-by":"crossref","unstructured":"Pignolo, A. et al. Vitamin D and Parkinson\u2019s disease. Nutrients 14(6) (2022).","DOI":"10.3390\/nu14061220"},{"issue":"3\u20134","key":"87120_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000441917","volume":"16","author":"KY Kwon","year":"2016","unstructured":"Kwon, K. Y. et al. Low serum Vitamin D levels may contribute to gastric dysmotility in de novo Parkinson\u2019s disease. Neuro Degener. Dis. 16(3\u20134), 199\u2013205 (2016).","journal-title":"Neuro Degener. Dis."},{"issue":"3","key":"87120_CR47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1042\/BST20140279","volume":"43","author":"MJ Berridge","year":"2015","unstructured":"Berridge, M. J. Vitamin D: A custodian of cell signalling stability in health and disease. Biochem. Soc. Trans. 43(3), 349\u2013358 (2015).","journal-title":"Biochem. Soc. Trans."},{"issue":"12","key":"87120_CR48","doi-asserted-by":"publisher","first-page":"621","DOI":"10.14423\/SMJ.0000000000001041","volume":"112","author":"CC Ferguson","year":"2019","unstructured":"Ferguson, C. C. et al. Dietary supplement use is high among individuals with Parkinson disease. South. Med. J. 112(12), 621\u2013625 (2019).","journal-title":"South. Med. J."},{"issue":"24","key":"87120_CR49","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1212\/WNL.0000000000003430","volume":"87","author":"LE Mokry","year":"2016","unstructured":"Mokry, L. E. et al. Genetically decreased vitamin D and risk of Alzheimer disease. Neurology 87(24), 2567\u20132574 (2016).","journal-title":"Neurology"},{"key":"87120_CR50","doi-asserted-by":"publisher","first-page":"26496","DOI":"10.1038\/srep26496","volume":"6","author":"AE Taylor","year":"2016","unstructured":"Taylor, A. E. et al. Investigating causality in the association between 25(OH)D and schizophrenia. Sci. Rep. 6, 26496 (2016).","journal-title":"Sci. Rep."},{"issue":"8","key":"87120_CR51","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/mds.27069","volume":"32","author":"SC Larsson","year":"2017","unstructured":"Larsson, S. C. et al. No clear support for a role for vitamin D in Parkinson\u2019s disease: A Mendelian randomization study. Mov. Disord. 32(8), 1249\u20131252 (2017).","journal-title":"Mov. Disord."},{"issue":"2","key":"87120_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1469-1809.2010.00631.x","volume":"75","author":"MW Butler","year":"2011","unstructured":"Butler, M. W. et al. Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann. Hum. Genet. 75(2), 201\u2013210 (2011).","journal-title":"Ann. Hum. Genet."},{"key":"87120_CR53","doi-asserted-by":"crossref","unstructured":"Barichella, M. et al. Vitamin D status and Parkinson\u2019s disease. Brain Sci. 12(6) (2022).","DOI":"10.3390\/brainsci12060790"},{"issue":"2","key":"87120_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11154-017-9424-1","volume":"18","author":"MF Holick","year":"2017","unstructured":"Holick, M. F. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev. Endocr. Metab. Disord. 18(2), 153\u2013165 (2017).","journal-title":"Rev. Endocr. Metab. Disord."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87120-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87120-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87120-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T01:59:00Z","timestamp":1739930340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87120-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87120"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87120-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The necessary Institutional Review Board approval for the federal NHANES data collection was obtained by the National Center for Health Statistics. Adult participants provided written informed consent. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2000. Since all statistical data used in this research were fully anonymized and publicly available, no additional ethical review was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"5514"}}